Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
Status:
Recruiting
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of favipiravir combined with
tocilizumab in the treatment of corona virus disease 2019.